Study record

MOTS-c attenuates placental vascular endothelial cell apoptosis in intrahepatic cholestasis of pregnancy by inhibiting K33-linked deubiquitination of BACH1

Li S, Ai L, Ge L et al. · Cell Commun Signal · 2026

AnimalSeveralEvidence tier CAlso: Human observationalAlso: Cell study (in vitro)

What this study reported

Measured lower MOTS-c in maternal serum and placental tissue from patients with intrahepatic cholestasis of pregnancy. Reported that in cholic acid-exposed mice, administered MOTS-c was associated with more placental angiogenesis, less endothelial apoptosis and higher birth weight, placental efficiency and neonatal survival, and that MOTS-c bound BACH1 and promoted its K33-linked ubiquitination and degradation, with BACH1 overexpression abolishing the effect in human umbilical vein endothelial cells.

Limitations

Clinical sample sizes not reported in the abstract; a single chemically induced mouse model of cholestasis and one endothelial cell type; mechanism rests on overexpression rather than placental genetic deletion.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Specieshuman, mouse
System studiedMaternal serum and placental tissue from intrahepatic cholestasis of pregnancy; cholic acid-induced mouse model; taurocholic acid-exposed HUVECs
Populationpregnant women with intrahepatic cholestasis of pregnancy and comparison samples
DesignClinical sample measurement with controlled animal and cell experiments
Sample size as reportednot reported
Control groupuntreated cholestatic mice and untreated exposed endothelial cells
Route (data field only)Not reported
Endpoints measuredmaternal serum and placental MOTS-c; placental angiogenesis; endothelial apoptosis and oxidative stress; BACH1 ubiquitination and SLC25A51 expression; offspring birth weight, placental efficiency and neonatal survival
Pathways measuredApoptosis · Oxidative stress · Other
Research areasPregnancy · Liver · Cardiovascular · Mitochondrial biology
Evidence tierC — Animal in vivo
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.